Hempel Gunther, Maier Anne-Marie, Piegeler Tobias, Stehr Sebastian N, Kratzsch Jürgen, Höhne Claudia
Department of Anesthesiology and Intensive Care, University of Leipzig Medical Center, 04103 Leipzig, Germany.
Department of Pediatric Cardiology, Leipzig Heart Center, 04289 Leipzig, Germany.
J Clin Med. 2020 Jul 6;9(7):2129. doi: 10.3390/jcm9072129.
Obesity in pediatric surgical patients is a challenge for the anesthesiologist. Despite potentially beneficial properties, propofol might also induce hypotension. This study examined whether a dose adjustment in overweight children could avoid hypotension and if there would be differences regarding hormonal regulation in children under anesthesia. Fifty-nine children undergoing surgery under general anesthesia were enrolled in this prospective observational trial. Participants were allocated into two groups according to their BMI. The induction of anesthesia was conducted using propofol ("overweight": 2 mg/kgBW, "regular": 3.2 mg/kgBW). The maintenance of anesthesia was conducted as total intravenous anesthesia. Hormone levels of renin, angiotensin II, aldosterone, copeptin, norepinephrine and epinephrine were assessed at different timepoints. Blood pressure dropped after the administration of propofol in both groups, with a nadir 2 min after administration-but without a significant difference in the strength of reduction between the two groups. As a reaction, an increase in the plasma levels of renin, angiotensin and aldosterone was observed, while levels of epinephrine, norepinephrine and copeptin dropped. By adjusting the propofol dosage in overweight children, the rate of preincision hypotension could be reduced to the level of normal-weight patients with a non-modified propofol dose. The hormonal counter regulation was comparable in both groups. The release of catecholamines and copeptin as an indicator of arginine vasopressin seemed to be inhibited by propofol.
小儿外科手术患者的肥胖问题对麻醉医生来说是一项挑战。尽管丙泊酚可能具有有益特性,但它也可能诱发低血压。本研究探讨了超重儿童调整丙泊酚剂量是否能避免低血压,以及麻醉状态下儿童在激素调节方面是否存在差异。59例接受全身麻醉手术的儿童参与了这项前瞻性观察性试验。根据BMI将参与者分为两组。使用丙泊酚进行麻醉诱导(“超重”组:2mg/kg体重,“正常”组:3.2mg/kg体重)。麻醉维持采用全静脉麻醉。在不同时间点评估肾素、血管紧张素II、醛固酮、 copeptin、去甲肾上腺素和肾上腺素的激素水平。两组在给予丙泊酚后血压均下降,给药后2分钟降至最低点,但两组血压下降幅度无显著差异。作为反应,观察到肾素、血管紧张素和醛固酮的血浆水平升高,而肾上腺素、去甲肾上腺素和copeptin水平下降。通过调整超重儿童的丙泊酚剂量,切口前低血压发生率可降至未调整丙泊酚剂量的正常体重患者水平。两组的激素代偿调节相当。丙泊酚似乎抑制了儿茶酚胺和作为精氨酸加压素指标的copeptin的释放。